Skip to main content

Day: August 21, 2023

NowVertical Group Announces Second Quarter 2023 Earnings Release Date, Financial Webinar and Completion of Q1 Review Engagement

TORONTO, Aug. 21, 2023 (GLOBE NEWSWIRE) — NowVertical Group Inc. (TSX-V: NOW) (OTCQB: NOWVF) (“NOW” or the “Company”), the vertical intelligence (VI) software and solutions company, will announce its 2023 second quarter financial results on Tuesday, August 29, 2023, after the market close, followed by a webinar at 9:30 AM EDT (6:30 AM PDT) on Wednesday, August 30, 2023 to discuss the Company’s financial and business results and outlook. NOW invites shareholders, analysts, investors, media representatives, and other stakeholders to attend our upcoming earnings webinar, where Sasha Grujicic, Chief Executive Officer, Andre Garber, Chief Development Officer and Alim Virani, Chief Financial Officer will discuss Q2 2023 results, followed by a question-and-answer session. In addition, the Company is pleased to announce that Company’s...

Continue reading

Mullen’s First Production Vehicle Rolls Off Assembly Line

Mullen achieves production milestone with first Mullen THREE, commercial Class 3 truck coming off the end of the assembly line at its Tunica, Mississippi-based assembly facilityMullen’s first production vehicles roll off the assembly lineThe first Mullen THREE photographed at Mullen’s Tunica, Mississippi, assembly plant.The Mullen THREE, a commercial Class 3 cab forward EV chassis truck, starting at $68,500 MSRPThe THREE is an efficient Class 3 with a clean top-of-rail for easy upfitting with bodies up to 14 feet long and over 5,800 pounds of payload.Mullen’s commercial Class 3 is produced in Tunica, MississippiTo date, Mullen has received $79 million in purchase orders for the Mullen THREE, Class 3 EV trucks.BREA, Calif., Aug. 21, 2023 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ:...

Continue reading

Complete Solaria Agrees to Terms to Sell Certain North American Solar Panel Assets

FREMONT, Calif., Aug. 21, 2023 (GLOBE NEWSWIRE) — Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (Nasdaq: CSLR), a leading solar technology, services, and installation company, today announced they have entered into a Non-Binding Letter of Intent to sell certain Complete Solaria’s North American solar panel assets to a global, tier-1 panel manufacturer. The agreement also includes a provision for the buyer to supply premium, high-power solar panels to Complete Solaria. Complete Solaria CEO, Will Anderson, said, “We are shifting our business away from manufacturing and toward our highest margin, most popular ‘total-service model’ in which we design, install, and warranty full solar systems. However, we will maintain access to our market-leading premium panels that support our end-to-end customer offering. Our Pro Partner...

Continue reading

Global Medical Exoskeleton Market Size to Reach USD 6.25 Billion 2030 | Emergen Research

Increasing number of individuals with physical disabilities and subsequent rise in demand for effective rehabilitation approaches is a significant factor driving the global medical exoskeleton market revenue growth Vancouver, Aug. 21, 2023 (GLOBE NEWSWIRE) — The global market for medical exoskeletons is projected to achieve a noteworthy growth trajectory, with an anticipated market value of approximately USD 6.25 Billion by the year 2030. This growth will be underpinned by a consistent revenue Compound Annual Growth Rate (CAGR) of around 45.0%, as analyzed by Emergen Research. This positive outlook is primarily attributed to substantial investments directed towards advancing exoskeleton technology. Illustrating this trend is the case of Wandercraft, a developer of exoskeletons located in Paris, which secured a substantial sum of...

Continue reading

Global Urinalysis Market Size to Reach USD 6.49 Billion 2030 | Emergen Research

Growing prevalence of Urinary Tract Infection (UTIs), liver & kidney diseases, and diabetes is a significant factor driving global urinalysis market revenue growth Vancouver, Aug. 21, 2023 (GLOBE NEWSWIRE) — The anticipated expansion of the global urinalysis market is projected to reach a valuation of approximately USD 6.49 Billion by the year 2030. This growth is forecasted to occur at a consistent and moderate Compound Annual Growth Rate (CAGR) of 7.2%, as outlined in the latest analysis conducted by Emergen Research. The driving forces behind this market growth are multifaceted. There is an increasing prevalence of conditions such as Urinary Tract Infections (UTIs), diabetes, and various kidney diseases including Chronic Kidney Disease (CKD), polycystic kidney disease, and acute kidney failure. This escalation in health...

Continue reading

Smart Share Global Limited Announces Second Quarter 2023 Results

Net income reached RMB24.5 million for the second quarter of 2023POIs1 operated under network partner model reached 62.0% as of the end of the second quarter of 2023Number of POIs reached 1.1 million as of the end of the second quarter of 2023 SHANGHAI, China, Aug. 21, 2023 (GLOBE NEWSWIRE) — Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced its unaudited financial results for the quarter ended June 30, 2023. HIGHLIGHTS FOR THE SECOND QUARTER OF 2023Net income for the second quarter of 2023 was RMB24.5 million, compared to a net loss of RMB184.5 million in the same period last year. As of June 30, 2023, the Company’s services were available in 1,109 thousand POIs, compared with 1,001 thousand as of March 31, 2023. As of...

Continue reading

Global Sleep Apnea Devices Market Size to Reach USD 12.88 Billion 2030 | Emergen Research

Increasing number of companies venturing into sleep apnea devices in addition to the oral applications industry is a significant factor driving global sleep apnea devices market revenue growth Vancouver, Aug. 21, 2023 (GLOBE NEWSWIRE) — Anticipated to attain a value of USD 12.88 billion by 2030, the global market for sleep apnea devices is poised to grow steadily with a compound annual growth rate (CAGR) of 6.9%, as per the latest analysis conducted by Emergen Research. This growth is primarily propelled by the expanding patient cohort characterized by undiagnosed sleep apnea cases. Notably, Obstructive Sleep Apnea (OSA) stands as the most prevalent form of sleep-disordered breathing, affecting around 37% of men and 50% of women. However, a staggering 80% of individuals grappling with OSA remain undiagnosed, hence devoid of treatment. It’s...

Continue reading

Permian Resources to Acquire Earthstone Energy in All-Stock Transaction, Creating a $14 Billion Premier Delaware Basin Independent E&P

MIDLAND, Texas and THE WOODLANDS, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) — Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) and Earthstone Energy, Inc. (“Earthstone Energy” or “Earthstone”) (NYSE: ESTE) today announced that they have entered into a definitive agreement under which Permian Resources will acquire Earthstone in an all-stock transaction valued at approximately $4.5 billion, inclusive of Earthstone’s net debt. Under the terms of the transaction, each share of Earthstone common stock will be exchanged for a fixed ratio of 1.446 shares of Permian Resources common stock. The transaction strengthens Permian Resources’ position as a leading Delaware Basin independent E&P with over 400,000 Permian net acres, pro forma production of approximately 300,000 Boe/d1 and an enhanced free cash flow...

Continue reading

Global Allergy Diagnostics Market Size to Reach USD 12.45 Billion 2030 | Emergen Research

High prevalence of allergic diseases is a significant factor driving the global allergy diagnostics market revenue growth Vancouver, Aug. 21, 2023 (GLOBE NEWSWIRE) — The latest analysis by Emergen Research anticipates that the global market for allergy diagnostics is poised to attain a noteworthy valuation of USD 12.45 Billion by 2030, exhibiting a consistent compound annual growth rate (CAGR) of 11.1% in terms of revenue. A primary catalyst steering the augmented revenue generation within this market is the notable upsurge in the prevalence of allergic ailments. For instance, allergic rhinitis, commonly referred to as hay fever, affects approximately 7.8% of the populace in the United States. Furthermore, statistics suggest that Immunoglobulin E (IgE)-mediated food allergies or sensitivities afflict around 3.5-4% of the general...

Continue reading

Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing

PONTE VEDRA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ Procedure, today announced Nathan Minnich has been appointed Sr. Vice President, Marketing, effective immediately. In this new position, Mr. Minnich will lead all aspects of Treace’s marketing efforts, with a focus on expanding the Company’s physician outreach, patient awareness and market penetration efforts.  “I am delighted to welcome Nathan to the Treace team,” said John T. Treace, CEO, Founder and Board Member of Treace. “During his career, Nathan has led the development, implementation and execution of successful marketing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.